EFFECT OF NEOADJUVANT CHEMOTHERAPY ON THE IMMUNE MICROENVIRONMENT IN MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Ikarashi, Daiki
Kitano, Shigehisa
Tsuyukubo, Takashi
Kato, Yoichiro
Nakatsura, Tetsuya
Maekawa, Shigekatsu
Kato, Renpei
Obara, Wataru
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD55-04
引用
收藏
页码：E998 / E998
页数：1
相关论文
共 50 条
  • [1] Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
    Sherif, Amir
    Winerdal, Malin
    Winqvist, Ola
    [J]. BLADDER CANCER, 2018, 4 (01) : 1 - 7
  • [2] NEOADJUVANT CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER
    Hazhir, Samad
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A54 - A54
  • [3] Neoadjuvant chemotherapy in muscle invasive bladder cancer
    Suer, Evren
    Turkolmez, Kadir
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (01): : 74 - 78
  • [4] Immune correlates of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Ginwala, Rashida
    Macfarlane, Alexander
    Liu, David
    Alpaugh, R. K.
    Xiu, Joanne
    Gatalica, Zoran
    Korn, W. M.
    Van Allen, Eliezer M.
    Campbell, Kerry S.
    Kutikov, Alexander
    Plimack, Elizabeth
    Abbosh, Philip H.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [5] Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
    Karaoglu, Aziz
    Oflazoglu, Utku
    Demir, Necla
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (01): : 58 - 63
  • [6] Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
    Ikarashi, Daiki
    Kitano, Shigehisa
    Tsuyukubo, Takashi
    Takenouchi, Kazumasa
    Nakayama, Takayuki
    Onagi, Hiroko
    Sakaguchi, Asumi
    Yamashita, Makiko
    Mizugaki, Hidenori
    Maekawa, Shigekatsu
    Kato, Renpei
    Kato, Yoichiro
    Sugai, Tamotsu
    Nakatsura, Tetsuya
    Obara, Wataru
    [J]. BRITISH JOURNAL OF CANCER, 2022, 126 (04) : 606 - 614
  • [7] Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
    Daiki Ikarashi
    Shigehisa Kitano
    Takashi Tsuyukubo
    Kazumasa Takenouchi
    Takayuki Nakayama
    Hiroko Onagi
    Asumi Sakaguchi
    Makiko Yamashita
    Hidenori Mizugaki
    Shigekatsu Maekawa
    Renpei Kato
    Yoichiro Kato
    Tamotsu Sugai
    Tetsuya Nakatsura
    Wataru Obara
    [J]. British Journal of Cancer, 2022, 126 : 606 - 614
  • [8] THE EFFECT OF INTRINSIC SUBTYPE ON RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
    Metcalfe, Michael
    Sundi, Debashish
    Li, Roger
    Ferguson, James
    Shanna, Pretzsch
    Jolanta, Bondaruk
    Czerniak, Bogdan
    Plimack, Elizabeth
    Navai, Neema
    Kamat, Ashish
    Dinney, Colin
    Shah, Jay
    Choi, Woonyoung
    McConkey, David
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E1194 - E1194
  • [9] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    [J]. EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [10] Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
    Jayaratna, Isuru S.
    Navai, Neema
    Dinney, Colin P. N.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) : 273 - 282
12345